8-K: HeartCore Reports Q2 2026 Results: Revenue Up, Losses Widen

HeartCore Enterprises announced second quarter 2026 financial results, showing a 71.6% revenue increase to $321,000 but a net loss of $2.0 million, a significant shift from the prior year's net income.

Summary

• HeartCore Enterprises reported financial results for the second quarter and first six months ended June 30, 2026.
• For Q2 2026, revenue increased by 71.6% to $321,000, driven by software development services from its Vietnamese subsidiary.
• However, gross loss widened to $70,000 from $23,000 in Q2 2025, and operating expenses increased slightly.
• The company reported a net loss of $2.0 million for Q2 2026, a substantial change from a net income of $1.1 million in the prior year's quarter.
• Adjusted EBITDA for Q2 2026 was $(1.3) million, compared to $(0.1) million in Q2 2025.
• For the six months ended June 30, 2026, revenue grew 25.9% to $554,000, while gross loss was $178,000 compared to a gross profit of $75,000 in the prior year.
• The net loss for the first six months of 2026 was $4.0 million, compared to $2.1 million in the same period last year.
• Adjusted EBITDA for the six months was $(2.9) million, compared to $(1.2) million in the prior year.
• As of June 30, 2026, the company had $587,000 in cash and cash equivalents, a decrease from $1,904,826 at the end of 2025.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to increased net losses, declining gross profit, and a significant decrease in cash reserves, despite revenue growth.

Positives

• Revenue increased by 71.6% to $321,000 in the second quarter of 2026 compared to the same period last year.
• Revenue increased by 25.9% to $554,000 for the first six months of 2026 compared to the same period last year.
• The company regained compliance with Nasdaq's $1.00 minimum bid price requirement.
• HeartCore Luvina Vietnam, the company's Vietnamese subsidiary, saw an increase in software development services revenue.
• The company is strategically divesting non-core assets (Sigmaways and HeartCore Luvina Vietnam) to focus on Go IPO consulting and financial services.

Negatives

• Gross loss increased to $70,000 in Q2 2026 from $23,000 in Q2 2025.
• Net loss for Q2 2026 was $2.0 million, a significant deterioration from a net income of $1.1 million in Q2 2025.
• Adjusted EBITDA for Q2 2026 was $(1.3) million, a worsening from $(0.1) million in Q2 2025.
• Gross loss for the first six months of 2026 was $178,000, compared to a gross profit of $75,000 in the prior year.
• Net loss for the first six months of 2026 was $4.0 million, compared to $2.1 million in the same period last year.
• Adjusted EBITDA for the first six months of 2026 was $(2.9) million, compared to $(1.2) million in the prior year.
• Cash and cash equivalents decreased significantly to $587,000 as of June 30, 2026, from $1,904,826 as of December 31, 2025.
• Go IPO consulting services revenue decreased due to fewer customers and IPO timeline extensions.

Risks

• The Nasdaq listing environment remains selective and compliance-driven, requiring disciplined client selection and thorough preparation.
• There is a risk that IPO customers may extend their IPO timelines, impacting Go IPO consulting revenue.
• The company is undergoing portfolio optimization, which involves divestitures that could impact short-term financial performance.
• Forward-looking statements are subject to known and unknown uncertainties and factors beyond the company's control that could materially affect actual results.

Future Outlook

The company believes that with a streamlined portfolio and a more focused pipeline, HeartCore is better positioned to deepen client relationships and advance its capital markets and financial services initiatives. Management is prioritizing clients with stronger fundamentals and readiness for U.S. regulatory and exchange-listing requirements.

Management Comments

• During the first half of 2026, we took decisive steps to simplify HeartCore's operating structure and sharpen our strategic focus.
• The divestiture of Sigmaways and the pending disposition of our 51% equity interest in HeartCore Luvina Vietnam represent important components of our ongoing portfolio optimization and will allow us to further concentrate resources on our core Go IPO and planned launch of our financial services business.
• The Nasdaq listing environment remains selective and compliance-driven, reinforcing the importance of disciplined client selection and thorough preparation.
• Accordingly, we are prioritizing opportunities with clients that we believe demonstrate stronger fundamentals, organizational readiness, and a clear path toward satisfying U.S. regulatory and exchange-listing requirements.
• With a streamlined portfolio and a more focused pipeline, we believe HeartCore is better positioned to deepen client relationships and advance its capital markets and financial services initiatives.

Industry Context

StockSavvy.ai notes that HeartCore operates in the competitive IPO consulting and financial advisory space, where market conditions, regulatory scrutiny, and client readiness significantly impact performance. The company's strategic shift towards core services and divestiture of non-essential assets aligns with industry trends of focusing on specialized, high-value offerings.

Comparison to Industry Standards

• No specific industry benchmarks or comparable company financial data were provided in the filing to facilitate a direct comparison.
• The filing mentions regaining compliance with Nasdaq's $1.00 minimum bid price, which is a standard requirement for listed companies.

Related Party Transactions

• Cost of revenues included transactions with a related party of $151,143 for the three months and $265,678 for the six months ended June 30, 2026.
• Accounts payable and accrued expenses related party was $33,946 as of June 30, 2026.
• Due to related party was $460 as of June 30, 2026.

Stakeholder Impact

• Shareholders may be concerned by the widening net losses and significant decrease in cash reserves, despite revenue growth.
• Employees may face uncertainty due to the company's strategic restructuring and focus on core services.
• Clients in the Go IPO consulting pipeline may experience extended timelines, impacting their own strategic plans.

Next Steps

• Continue to concentrate resources on core Go IPO consulting and the planned launch of the financial services business.
• Prioritize opportunities with clients demonstrating stronger fundamentals and readiness for U.S. regulatory and exchange-listing requirements.
• Advance capital markets and financial services initiatives with a streamlined portfolio and focused pipeline.

Key Dates

Recommendation

The significant increase in net losses, widening gross loss, and substantial decrease in cash reserves, despite revenue growth, indicate deteriorating financial health. The company's strategic divestitures, while aimed at long-term focus, have not yet translated into profitability, making the current financial performance a concern for investors.

Keywords

IPO consulting, financial results, revenue growth, net loss, capital markets, divestiture, software development, Nasdaq compliance